Quality Risk Management: Excipients

Similar documents
Annex 6. Good trade and distribution practices for pharmaceutical starting materials

Increasing Focus on Excipients

Counterfeit Drugs and Supply Chain Security

Questionnaire Layout:

Contents. Contents (13) 1 Production (23)

IPEC Present & Future. Excipient Fest Janeen Skutnik Chair IPEC Americas

GOOD TRADE AND DISTRIBUTION PRACTICES FOR PHARMACEUTICAL STARTING MATERIALS. REVISION

Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00

Holding Your Suppliers Accountable

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

The Importance of Supplier Qualification of the Full Distribution Life-cycle in Pharmaceuticals

USP General Chapter <1079> Pharmacopeia Forum. for Drug Products

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

The IPEC Quality Agreement Guide and Template

Current Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing.

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

GMPs: Distribution Centers

Table of Contents. Legal Notices... 61

GMP On Site Series. GMP Essentials

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

Annex 4. Assessment tool based on the model quality assurance system for procurement agencies: aide memoire for inspection

Approved Supplier Guidance

FSMA Food Safety Seminar Japan External Trade Organization

Supplier Assurance Program. CBE Pty Ltd

Trotz sorgfältiger inhaltlicher Prüfung übernehmen wir keine Haftung für die Richtigkeit und Aktualität für Unterlagen von Dritten.

WHO guidelines on quality risk management

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Section: Attaining Food Safety. Subject: Non- Conforming Product or Equipment

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators

Annex 14 WHO guidelines for drafting a site master file 136

ICH Quality Implementation Working Group POINTS TO CONSIDER

Guide for Distributors of Medical Devices

Inspections, Compliance, Enforcement, and Criminal Investigations

GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS

Brussels, C(2017) 8179 final. Guidelines

EU and FDA GMP Regulations: Overview and Comparison

Annex 4. Guidance on good manufacturing practices: inspection report. Background

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

What s most recent in EDQM Inspections?

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Good Manufacturing Practices Guidance Document

Enabling Improvement through the Product Lifecycle: Change Management within a PQS

MSC Chain of Custody Standard: Consumer-Facing Organisation (CFO) Version

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould


GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART II

Inspection. Implementation of ICH Q8, Q9, Q10

Revision of Chapter 7 Contract Manufacture and Analysis

Lifecycle Product Quality Risk Management

Developing a Robust Quality System to Assure Data Integrity

Challenges in Implementing Knowledge Management within ICH Q10

PAI Inspections, Observations and Data Integrity

THE NEW QUALITY PARADIGM OPPORTUNITIES AND EXPECTATIONS IN ICH Q8 Q9 Q10 Q11 DR. FRITZ ERNI

Combination Products Part 4 Compliance and Implementation at multi-site Network

MEASURE FOR MEASURE: QUALITY METRICS

ECIA Distributor Counterfeit Product Mitigation Internal Audit Checklist

MSC Chain of Custody Standard: Group Version

<1079> Good Storage and Distribution Practices

The Joint IPEC PQG Good Manufacturing Practices Audit Guide

NSF International Standard / American National Standard. NSF/IPEC/ANSI Good Manufacturing Practices (GMP) for Pharmaceutical Excipients

Quality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union Volume 4

MSC Chain of Custody Standard: Default Version

EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT

UPPLIER ANUAL. Issued: 01 Aug 13

Examining the New SQF Quality Code: How to Comply by the January Deadline

Audits must be conducted with due concern for employee safety and environmental protection.

PCI Pharmaceutical Consulting

4. RELATED DOCUMENTS AND FORMS 4.1. AS ISO Cambridge Valley Machining, Inc. QMS procedures, including, but not limited to:

GIRP comments on. The vital link in healthcare 1. European Association of Pharmaceutical Full-line Wholesalers

Conducting Supplier Audits: Ensure Validation Compliance

Revision. Quality Manual. Multilayer Prototypes. Compliant to ISO / AS9100 Rev C

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

APIC GUIDE FOR AUDITING REGISTERED STARTING MATERIAL MANUFACTURERS Version February, 2018

Enhanced Quality Product Documentation

Updates on Quality Metrics - Industry Perspectives Dan Snider Vice President, Research and Development Mylan Inc.

Guidance Document. Meeting Requirements as a Registered Food Importer. A guidance document issued by the Ministry for Primary Industries

The APIC Audit Programme Version 5, July 2017

Commission Guidelines on Good Distribution Practice of Medicinal Products for Human Use

VOLUME 4 Good manufacturing practices ANNEX 13 Manufacture of investigational medicinal products JULY 2003

Quality Assurance Procedure Issued: 15NOV2017 Page 1 of 11

QM-001(Rev. 1) 1.0 INTRODUCTION. 1.1 Scope

Guide to Quality System for General Sale Wholesale Distributors

FDA Drug Compliance. Pepe Rodriguez-Perez, PhD Business Excellence Consulting Inc / BEC Spain SL.

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology

Clinical Trial Supplies. Establishing Firm Grounds for your Trials

QUALITY MANUAL. Conforming To AS9120B and ISO9001:2015. QM-001 Page 0 of 32 Revision 22:

Association of American Railroads Quality Assurance System Evaluation (QASE) Checklist Rev. 1/12/2017

QUALITY DEPT request to have FORM 1135 for REVIEW/APPROVAL Cycle everytime form will be updated/revised.

Excipient Certification: Schemes and Auditable Standards - the role in Supplier Qualification

An FDA Perspective on Atypical Active Ingredients

American Association for Laboratory Accreditation

Qualified Persons in the Pharmaceutical Industry Study Guide

An is all it takes to change the way you work..!

Transcription:

Quality Risk Management: Excipients ExcipientFest 2012 Presented by: Londa Ritchey, M.S. Director, Supplier Qualification Global Quality Operations Pfizer, Inc.

Agenda Regulatory Environment Material Quality System Elements On-Going Monitoring Risk Management Summary 2

Today s Focus Integration of QRM into Material Quality Systems Requirements Note: This is one Pharma User s perspective 3

Why Focus on Ingredients? Regulatory expectations of Ingredient Safety are evolving 4

Increased Regulatory Expectation Quality Risk Management Security of the Supply Channel On Site Audits of Material Suppliers Capture Material Supply Channels Quality Agreements with Critical Material Suppliers Supplier s Suppliers Supplier- Original Mfg Repacker Distributor Warehouse Pharma production site Supplier s Suppliers Material Supply Channel Expectations Capture each material Supply chain to each pharma location Capture each Supplier and Role for each material Each Party in the Supply Channel evaluated against the appropriate quality standard

Quality Systems Guidance Management of Outsourced Activities and Purchased Materials- ICH Q10- Section 2.7 (a) Assessing.the suitability and competence to carry out the activity or provide the material using a defined supply chain (e.g., audits, material evaluations, qualification); (b) Defining the responsibilities and communication processes for quality related activities of the involved parties. (c) Monitoring and review of the quality of the material from the supplier, and the identification and implementation of any needed improvements; (d) Monitoring incoming ingredients and materials to ensure they are from approved sources using the agreed supply chain. Quality Risk Management- ICH Q9

Material System Elements Pre- Use Pharma User- Material System Use Period Post- Use Robust Quality System Evaluation & Approval of Materials Evaluation & Approval of Suppliers Receipt and Inspection Sampling and Testing Retain Management Destruction Procedural Controls Training/ Qualification GMP Documentation Investigations Computerized Systems Validation Core Requirements Acceptance Criteria Inventory Control CAPA Monitoring Change Management Management Review ICH Q10 Storage

Managing Material Sourcing Risks Material Risks Material Precursors Origins of the material BSE/TSE, GMO Allergens, Residual solvents other material source risks Process capability, CQA defined Specificity of test method, Incentive/demand Supplier Risks Primary industry serviced, Pre-audit Quality assessment, Audit rating, Category sourced Country of Mfg Quality History Quality Agreement Open CAPA Control of starting materials Quality Culture Supply Channel Risks Transparency Number of parties in SC Repackaging /Relabeling Tamper Evidence Original Mfg CoA, other documentation Transportation qualification Associated Parties- direct access 8

Capturing Supply Channels Essential to understanding Material, Supplier and Supply Channel risks Sub-roles for Processor Note: The data shown here has been created solely for the purposes of presenting an example and does not reflect confidential supplier data Each supplier must have a qualification status prior to Approval of Supply Channel

Collect and review material risk data Material Sourcing Questionnaires GMP Pre-audit assessment Security Allergens, GMO BSE/TSE Residual Solvents Other General Material Questions Material Supply Channel Survey Know Critical Quality Attributes of Material Material Qualification Understand Process Capability/normal process variability for Material Understand Stability of Material Share Intended Pharmaceutical use with Supplier Qualify material in process and stability System for Material Approval should include review and acceptance of Material Supply Channel 10

1. Evaluate Pre-Qualification Risk Profile Security Questionnaire Pre-Audit Questionnaire Business intelligence Supplier Approval 9. Continuous improvement initiatives 10. Supplier Quality Metrics review 11. Re-assessments of supplier status - max. frequency 2. Quality Systems Audit 3. Quality Agreement 4. Risk Control plan for outstanding concerns 5. Document Approval decision 6. Monitor compliance to specifications, QA and MFG standards 7. Complaints/CAPA management and trending 8. Notification Management- change, Quality, other 11

Supplier Audit Considerations Auditor(s) focus on material category and Pre-Qualification Risk Profile Re-audit frequencies based on: Material type On-going risk profile Performance history Document specific Supply Channel Management reviews Review Changes since last audit Audit specific role of Supplier in Supply Chain GMP, GDP, GIP Elevate significant findings immediately for management review Update Risk profile and create risk control plan as needed Sample Audit Questions-SCS SUPPLY CHAIN SECURITY Is there a supply chain security program/plan? Is there awareness / sensitivity around the importance of supply chain security? Do they have procedures and processes in place to prevent supply chain related adulteration, diversion, and counterfeiting? Are there procedures in place to respond to supply chain related events? Is there a good supplier quality management program (selection, oversight, etc.) that incorporate supply chain risks? Are there effective processes and databases for supply chain transparency? Do the supplier quality management principles extend to warehousing and transportation providers? Are any processes in place to gather supply chain related intelligence from the market? 12

Cover the supply channel parties for Ingredient materials with Agreements Agreements with all Distributors and Repackers of Ingredients Template language to include security provisions Define roles/responsibilities/ communication pathways Change notifications, quality events, etc Subcontractor and supplier controls Approval signifies Acknowledgement that material is used for a pharmaceutical product intended for human consumption. Sample Supply Chain Integrity provisions for agreement Quality Agreement Considerations Supplier shall utilize tamper evidence packaging. Supplier shall provide identifying information on tamper evidence device(s) as requested. Supplier shall maintain knowledge of the original manufacturers of each critical material used in the production and packaging of Material intended for Customer. Supplier shall Qualify transportation services/carriers contracted by Supplier to distribute Material to customer, as relates to maintaining the quality and integrity of the Material enroute to Customer. 13

Acceptance Criteria Formal agreement on specifications for materials May be documented in a quality agreement, specification agreement, or material approval document Critical quality attributes for materials should be defined based on Use- specifications should include these Change Management required for specifications Quality Agreement includes change notification requirements Understand packaging (including tamper evidence) and shipping requirements for materials Retest or expiry dating from Supplier should be justified by data (and documented) 14

Receipt and Inspection OBSERVE Keep a general awareness of material drums and package appearance, for example: color, size, closure, label, container markings tamper evidence device If there is a tamper evidence device, is it intact? Subtle or obvious damage to container(s) Change in receiving paperwork, CoA, CoC, Bill of Lading, other certifications, etc. REPORT Any person who notes a discrepancy has the responsibility to report it to a Supervisor Review the finding as soon as possible with QA Use pictures to capture discrepancies, if possible. Document and follow-up with the supplier for clarifying discrepancies Observe & Report Provide Overall Economic Adulteration Awareness Training 15

The number of containers to be sampled should consider Sampling and Testing component attribute variability past quality history of the supplier quantity needed for reserve where required degree of precision desired confidence levels material risk profile information quantity needed for analysis and The tests performed should be consistent with risk profile. High Risk materials- may require additional tests or samples Use Information from the Material Risks Questionnaires Additional Surveillance testing may be needed for Supply Chain Security risks Material Test Method specificity Impurity Monitoring Discrepancies should be investigated and notification to Supplier Trending of discrepancies/abnormalities and review with management Note, When accepting test results from a Supplier s CoA, The Supplier also becomes a Contract Laboratory 16

Inventory Control and Storage Monitored & secure inventory. Documented material use Reconciliation procedures & investigations for out of tolerance reconciliation( +/-) Bags or boxes shall be stored off the floor Material shall be handled and stored in a manner to prevent contamination Segregated areas should be provided for the storage of rejected, recalled or returned materials Review of pallets composition to assure no TBA issues Storage area monitored for temp, humidity. Alarms, investigation for out of tolerance. Must be electronic or physical segregation of materials in different status 17

Retains stored under storage conditions listed on original material label Stored in limited access area Destruction of retains past defined retain period Stored in packaging consistent/similar in composition to material package at receipt Retains and Destruction Rejected components, shall be identified and controlled under a quarantine system designed to prevent their use. Rejected materials and products should be clearly marked as rejected and stored separately in restricted areas. They should either be returned to the suppliers or, where appropriate, reprocessed or destroyed

On-going Monitoring Signals for change in Risk Profile Supplier Performance E-systems enable information sharing & alerts regarding supplier performance Complaints CAPA Change Management Quality Notifications Quality Agreement Conformance Timely & Adequate Response, Trends Preventative Focus, On-time Prior to Change Quality Mgmt Timely Notices Quality Event Analysis Operation & Notifications as Agreed 19

Embedded Quality Risk Management Supplier Selection -risk evaluations SCS risks, Quality risk, Business risk, EHS risk Document quality agreement or audit refusals Evaluate Quality Issues Notifications coming from supplier Material Shortage notifications Known material adulteration events Critical Industry events Quality Event Risk Evaluation 1) Impact to patient safety and compliance 2) Impact to product released, materials in warehouse, next incoming receipt 3) Possible mitigations 4) Initial use of or continued use decision 5) Quality Management approval QP as applicable Documented

In Summary. Define requirements for Material Quality System in Procedures Procedures should embed steps for risk evaluation and decision points Continuous monitoring of risk profile is needed GMP Documentation required for each quality system step and risk decision Procedures should require investigation of discrepancies Embed Quality Risk Management into Supplier Quality Management Systems 21